All Blog Posts Tagged 'computed' (3)

Multidisciplinary Approach to Screening for and Treating Lung Cancer: Low Dose Computed Tomography Screening Proves Important in Detecting Lung Cancer

November is Lung Cancer Awareness Month. Lung cancer is the leading cause of cancer death for both men and women in the United States. It has a five-year survival rate of only 15 percent. Often, lung cancers grow silently for many years and reach an advanced stage before causing symptoms that lead to diagnosis and treatment. But, there is some good news. Research from the National Cancer…

Continue

Added by Editorial Team on November 5, 2012 at 12:30pm — No Comments

First Validated Screening Leads to 20% Reduction of Mortality Due to Lung Cancer.

Scientists have found a 20% percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published online today in the New England Journal of Medicine.

This article provides a… Continue

Added by Peter Hofland, PhD on June 29, 2011 at 8:30pm — No Comments

Imatinib Mesylate After Surgery Dramatically Reduces Risk of Cancer Returning in Patients with Gastrointestinal Stromal Tumors

The U.S. Food and Drug Administration, in late December 2008, approved imatinib mesylate (Glivec®, Novartis AG, Lichtstrasse 35, 4056 Basel, Switzerland and Gleevec®, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, NJ) for the post-surgery treatment of adult patients following complete surgical removal of KIT (CD117)-positive gastrointestinal stromal tumors (GIST).

The tyrosine kinase inhibitor imatinib mesylate is now the only post-surgery treatment… Continue

Added by Peter Hofland, PhD on January 19, 2009 at 6:00pm — No Comments